Aaron Ondrey serves as Executive at Mirati Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Aaron Ondrey has executed 7 insider transactions totaling $4.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 3, 2025 involved selling 1,477 shares valued at $4.3K.
Aaron Ondrey currently holds 128,173 shares of Mirati Therapeutics, Inc. (MRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Ondrey has been a net seller of MRTX stock. They have purchased $0 and sold $4.3K worth of shares.
Aaron Ondrey's most recent insider trade was on Jul 3, 2025, when they sold 1,477 shares at $2.88 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 23, 2024 | MRTX | $0 | Disposition | 17,021 | $N/A | Discretionary |
| Jan 23, 2024 | MRTX | $0 | Disposition | 1,302 | $N/A | Discretionary |
| Jan 23, 2024 | MRTX | $0 | Disposition | 21,138 | $N/A | Discretionary |
| Dec 29, 2023 | MRTX | $1000.0K | Award | 17,021 | $58.75 | Discretionary |
| Sep 8, 2023 | MRTX | $300.0K | Award | 8,412 | $35.66 | Discretionary |